Abstract
BackgroundTravel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity. Aim: The objective of this study was to estimate the risk for hepatitis A among European travellers using surveillance and travel denominator data. Methods: We retrieved hepatitis A surveillance data from 13 European Union (EU)/ European Economic Area (EEA) countries with comprehensive surveillance systems and travel denominator data from the Statistical Office of the European Union. A travel-associated case of hepatitis A was defined as any case reported as imported. Results: From 2009 to 2015, the 13 countries reported 18,839 confirmed cases of hepatitis A, of which 5,233 (27.8%) were travel-associated. Of these, 39.8% were among children younger than 15 years. The overall risk associated with travel abroad decreased over the period at an annual rate of 3.7% (95% confidence interval (CI): 0.7–2.7) from 0.70 cases per million nights in 2009 to 0.51 in 2015. The highest risk was observed in travellers to Africa (2.11 cases per million nights). Cases more likely to be reported as travel-associated were male and of younger age (< 25 years). Conclusion: Travel is still a major risk factor for HAV infection in the EU/EEA, although the risk of infection may have slightly decreased in recent years. Children younger than 15 years accounted for a large proportion of cases and should be prioritised for vaccination.
Highlights
Travel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity
The objectives of this study were to describe the epidemiology of travel-associated hepatitis A, to estimate the risk for hepatitis A among travellers from European Union (EU)/Economic Area (EEA) countries and to identify groups at higher risk to help target and prioritise interventions
Our findings provide a good picture of the epidemiology of travel-associated hepatitis A in Europe in recent years
Summary
Travel to countries with high or intermediate hepatitis A virus (HAV) endemicity is a risk factor for infection in residents of countries with low HAV endemicity. In Europe, the incidence of hepatitis A decreased substantially [5,6] and most countries in the European Union (EU)/ European Economic Area (EEA) currently experience low or very low HAV endemicity [7]. In such populations with an increasing proportion of susceptible individuals, travel is an important risk factor for infection [2,6]. European travellers to countries with high HAV endemicity are often infected when consuming contaminated food items or drinks during travel [8,9]. A similar epidemiology is observed in other highincome countries such as the United States (US) where ca 40% of all hepatitis A cases are travel-associated [10]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.